# Pharmaceuticals: Value chain, from upstream to the customer Drug discovery, manufacturing and distribution, from small-molecule generics to biologics Source page: https://www.materialinsights.org/industries/pharmaceuticals/value-chain/ #### Value chain, from upstream to the customer **Criticality to the chain:** 5 · Chokepoint 4 · Critical 3 · Important 2 · Supporting 1 · Commodity service Stage 1 **Discovery and developmentInnovator pharma and biotech companies**4 · Critical Discover new molecules, run clinical trials and hold the patents and approvals that let them sell branded medicines at a premium for about a decade.^[1](https://www.efpia.eu/media/owqczcqz/the-pharmaceutical-industry-in-figures-2026.pdf) **Why critical:** New medicines come from a few dozen large firms and many venture-funded biotechs, the US takes 74% of sales of medicines launched in 2020-24^[1](https://www.efpia.eu/media/owqczcqz/the-pharmaceutical-industry-in-figures-2026.pdf), and a patented drug has no substitute until generics arrive. Technologies Target biology and genomics Medicinal chemistry and AI-assisted design Monoclonal antibodies GLP-1 and peptide drugs Cell and gene therapy Depends on Chemicals [Rgt Reagents and high-purity lab chemicals](https://www.materialinsights.org/chemicals/lab_reagents/)[Pep Peptides and oligonucleotides](https://www.materialinsights.org/chemicals/peptides_oligos/)[Chi Chiral and specialty building blocks](https://www.materialinsights.org/chemicals/chiral_building_blocks/) Energy [Bld Energy in buildings](https://www.materialinsights.org/energy/e_buildings/)[DC Data centres](https://www.materialinsights.org/energy/e_data_centres/) Industries [Education and research](https://www.materialinsights.org/industries/education_research/)[Finance: banking, insurance, markets](https://www.materialinsights.org/industries/finance/)[Software and IT services](https://www.materialinsights.org/industries/software_it/)**Examples:** Eli Lilly, Novo Nordisk, Roche, Merck & Co., Zydus Lifesciences **Contract research organisations (CROs)**3 · Important Run preclinical studies and clinical trials, and handle data and regulatory filings for drug developers. **Why important:** Several large global CROs and many regional ones exist, but switching mid-trial costs months. Technologies Clinical trial management systems Bioanalytical labs Electronic data capture Real-world evidence analytics Depends on Chemicals [Rgt Reagents and high-purity lab chemicals](https://www.materialinsights.org/chemicals/lab_reagents/) Energy [Bld Energy in buildings](https://www.materialinsights.org/energy/e_buildings/) Industries [Healthcare services](https://www.materialinsights.org/industries/healthcare/)[Software and IT services](https://www.materialinsights.org/industries/software_it/)**Examples:** IQVIA, ICON, Syngene International, Veeda Clinical Research Stage 2 **Starting materials and inputsKey starting material and intermediate makers**5 · Chokepoint Make the fine chemicals and fermentation products (KSMs, intermediates, 6-APA, 7-ACA) from which APIs are synthesised.^[4](https://www.businesstoday.in/amp/industry/story/domestic-api-production-has-begun-but-imports-still-high-govt-tells-house-486671-2025-07-28)^,^[6](https://www.policyedge.in/p/rajya-sabha-q-and-a-indias-dependence) **Why chokepoint:** Nearly three-quarters of India's API and intermediate imports by value come from China, and for antibiotics such as penicillin there is no near-term alternative; India's PLI scheme had built capacity for only 25 APIs, KSMs and intermediates by March 2025^[4](https://www.businesstoday.in/amp/industry/story/domestic-api-production-has-begun-but-imports-still-high-govt-tells-house-486671-2025-07-28)^,^[6](https://www.policyedge.in/p/rajya-sabha-q-and-a-indias-dependence). Technologies Multi-step organic synthesis Large-scale fermentation Continuous flow chemistry Solvent recovery Depends on Commodities [Su Sugar](https://www.materialinsights.org/commodities/sugar/)[Mz Maize](https://www.materialinsights.org/commodities/maize/) Chemicals [KSM Pharma starting materials and intermediates](https://www.materialinsights.org/chemicals/ksm_intermediates/)[6APA Antibiotic intermediates (6-APA, 7-ACA)](https://www.materialinsights.org/chemicals/antibiotic_intermediates/)[MeOH Methanol](https://www.materialinsights.org/chemicals/methanol/)[Tol Toluene](https://www.materialinsights.org/chemicals/toluene/)[AcOH Acetic acid](https://www.materialinsights.org/chemicals/acetic_acid/)[HCl Hydrochloric acid](https://www.materialinsights.org/chemicals/hydrochloric_acid/) Energy [Tc Thermal coal](https://www.materialinsights.org/energy/thermal_coal/)[Blr Boilers, furnaces and stoves](https://www.materialinsights.org/energy/e_combustion_heat/) Industries [Water and sanitation](https://www.materialinsights.org/industries/water_sanitation/)**Examples:** Zhejiang Huahai Pharmaceutical, Shandong Xinhua Pharmaceutical, Aarti Pharmalabs, Aurobindo Pharma (penicillin G) **Excipient and capsule suppliers**3 · Important Supply the binders, fillers, coatings and empty capsules that turn an API into a tablet or capsule. **Why important:** Several qualified suppliers exist, but changing an excipient source needs regulatory variation filings. Technologies Microcrystalline cellulose production Film-coating systems Gelatin and HPMC capsules Spray drying Depends on Commodities [Tm Timber](https://www.materialinsights.org/commodities/lumber/)[Mz Maize](https://www.materialinsights.org/commodities/maize/) Chemicals [Exc Pharmaceutical excipients](https://www.materialinsights.org/chemicals/excipients/)[Str Starch and cellulose derivatives](https://www.materialinsights.org/chemicals/starch_derivatives/)[TiO2 Titanium dioxide](https://www.materialinsights.org/chemicals/titanium_dioxide/)[Glyc Glycerine](https://www.materialinsights.org/chemicals/glycerine/) Energy [HI Energy-intensive industry](https://www.materialinsights.org/energy/e_heavy_industry/)**Examples:** Roquette, Colorcon, ACG Worldwide, Sigachi Industries Stage 3 **API and biologics manufacturingAPI manufacturers and CDMOs**4 · Critical Synthesise active pharmaceutical ingredients to GMP standards for their own formulations or under contract for innovators and generic firms. **Why critical:** Each approved API source is named in the drug filing, so replacing one needs new validation batches and a regulatory variation, typically a year or more (estimate). Technologies cGMP multipurpose reactors Crystallisation and milling High-potency containment Process analytical technology Depends on Chemicals [API Small-molecule APIs](https://www.materialinsights.org/chemicals/apis/)[KSM Pharma starting materials and intermediates](https://www.materialinsights.org/chemicals/ksm_intermediates/)[CDMO Custom synthesis (CDMO)](https://www.materialinsights.org/chemicals/custom_synthesis/)[N2 Nitrogen gas](https://www.materialinsights.org/chemicals/nitrogen_gas/)[IPA Isopropanol](https://www.materialinsights.org/chemicals/isopropanol/) Energy [Blr Boilers, furnaces and stoves](https://www.materialinsights.org/energy/e_combustion_heat/)[HP Heat pumps, air conditioning and refrigeration](https://www.materialinsights.org/energy/e_heat_pumps/)[Dist Distribution grids, mini-grids and interconnectors](https://www.materialinsights.org/energy/e_distribution/) Industries [Water and sanitation](https://www.materialinsights.org/industries/water_sanitation/)[Machinery and equipment](https://www.materialinsights.org/industries/machinery/)**Examples:** Divi's Laboratories, Laurus Labs, Lonza, WuXi AppTec, Siegfried **Biologics and vaccine manufacturers**4 · Critical Grow cells or microbes in bioreactors to make antibodies, insulin, vaccines and biosimilars, for themselves or as contract makers. **Why critical:** Large-scale bioreactor capacity sits with a few firms in Korea, Switzerland, China and India, and tech transfer takes over a year. Technologies Mammalian cell culture Single-use bioreactors Chromatography purification Fill-finish in isolators Cold-chain release testing Depends on Commodities [Su Sugar](https://www.materialinsights.org/commodities/sugar/) Chemicals [Lys Amino acids (lysine, methionine)](https://www.materialinsights.org/chemicals/amino_acids/)[Pep Peptides and oligonucleotides](https://www.materialinsights.org/chemicals/peptides_oligos/)[PP Polypropylene](https://www.materialinsights.org/chemicals/polypropylene/)[CO2 Carbon dioxide](https://www.materialinsights.org/chemicals/carbon_dioxide/) Energy [HP Heat pumps, air conditioning and refrigeration](https://www.materialinsights.org/energy/e_heat_pumps/)[Dist Distribution grids, mini-grids and interconnectors](https://www.materialinsights.org/energy/e_distribution/) Industries [Water and sanitation](https://www.materialinsights.org/industries/water_sanitation/)[Plastic and rubber products](https://www.materialinsights.org/industries/plastic_rubber/)**Examples:** Samsung Biologics, Lonza, Serum Institute of India, Biocon Biologics Stage 4 **Formulation and packagingFinished-dose formulators (branded and generic)**3 · Important Turn APIs into tablets, injectables and inhalers, file dossiers with regulators and sell to wholesalers, hospitals and governments.^[3](https://newsonair.gov.in/indias-pharmaceutical-exports-reach-over-30-billion-dollar-in-financial-year-2024-25) **Why important:** Most generics have several approved makers, but sterile injectables have few, causing recurring shortages. Technologies Granulation and tableting Sterile injectables Modified-release formulations Bioequivalence studies Serialisation Depends on Chemicals [API Small-molecule APIs](https://www.materialinsights.org/chemicals/apis/)[Exc Pharmaceutical excipients](https://www.materialinsights.org/chemicals/excipients/)[APAP Paracetamol](https://www.materialinsights.org/chemicals/paracetamol/) Energy [HP Heat pumps, air conditioning and refrigeration](https://www.materialinsights.org/energy/e_heat_pumps/)[Dist Distribution grids, mini-grids and interconnectors](https://www.materialinsights.org/energy/e_distribution/) Industries [Paper and packaging](https://www.materialinsights.org/industries/paper_packaging/)[Water and sanitation](https://www.materialinsights.org/industries/water_sanitation/)[Machinery and equipment](https://www.materialinsights.org/industries/machinery/)**Examples:** Sun Pharmaceutical, Cipla, Dr. Reddy's Laboratories, Teva, Sandoz **Primary pharma packaging makers**4 · Critical Make glass vials, syringes, blister films, foil and stoppers that touch the drug and keep it sterile and stable. **Why critical:** Pharma-grade borosilicate tubing comes from very few producers, a bottleneck exposed in the Covid vaccine rollout. Technologies Type I borosilicate glass tubing Prefillable syringes Cold-form aluminium blisters Elastomer stoppers Depends on Commodities [Qz Silica sand](https://www.materialinsights.org/commodities/industrial_sand/)[B Boron](https://www.materialinsights.org/commodities/boron/)[Al Aluminium](https://www.materialinsights.org/commodities/aluminum/) Chemicals [PVC PVC](https://www.materialinsights.org/chemicals/pvc/)[Sil Silicones](https://www.materialinsights.org/chemicals/silicones/)[PP Polypropylene](https://www.materialinsights.org/chemicals/polypropylene/) Energy [Gas Natural gas](https://www.materialinsights.org/energy/natural_gas/)[HI Energy-intensive industry](https://www.materialinsights.org/energy/e_heavy_industry/) Industries [Plastic and rubber products](https://www.materialinsights.org/industries/plastic_rubber/)[Paper and packaging](https://www.materialinsights.org/industries/paper_packaging/)**Examples:** Schott, Gerresheimer, West Pharmaceutical Services, Schott Poonawalla, ACG Worldwide Stage 5 **Regulation and quality assuranceDrug regulators and pharmacopoeias**5 · Chokepoint Approve medicines, inspect plants against GMP, set quality standards and recall unsafe products; approval is the licence to sell. **Why chokepoint:** There is one regulator per market; a US FDA warning letter or import alert can cut a plant off from its largest market overnight. Technologies Dossier review (CTD) GMP inspections Pharmacovigilance Pharmacopoeial monographs Depends on Chemicals [Rgt Reagents and high-purity lab chemicals](https://www.materialinsights.org/chemicals/lab_reagents/) Energy [Bld Energy in buildings](https://www.materialinsights.org/energy/e_buildings/) Industries [Public administration, defence and security](https://www.materialinsights.org/industries/public_admin/)**Examples:** US FDA, European Medicines Agency, CDSCO, Indian Pharmacopoeia Commission Stage 6 **DistributionPharmaceutical wholesalers and stockists**3 · Important Buy from manufacturers and deliver many times a day to pharmacies and hospitals, handling cold chain, credit and returns. **Why important:** Three firms dominate US wholesale, while India has a fragmented network of stockists that is easy to switch but hard to bypass. Technologies Temperature-controlled warehouses Track-and-trace serialisation Demand forecasting B2B ordering apps Depends on Energy [PCM Latent heat and cold storage](https://www.materialinsights.org/energy/e_latent_heat/)[ICV Combustion road vehicles](https://www.materialinsights.org/energy/e_road_ice/) Industries [Transport and logistics](https://www.materialinsights.org/industries/transport_logistics/)[Wholesale and retail trade](https://www.materialinsights.org/industries/wholesale_retail/)**Examples:** McKesson, Cencora, Cardinal Health, Entero Healthcare Solutions Stage 7 **DispensingRetail, hospital and online pharmacies**2 · Supporting Dispense medicines to patients on prescription or over the counter, and advise on use. **Why supporting:** Hundreds of thousands of outlets compete; patients can switch pharmacies at once. Technologies Pharmacy management software E-prescriptions Online ordering and delivery Generic substitution (Jan Aushadhi) Depends on Energy [Bld Energy in buildings](https://www.materialinsights.org/energy/e_buildings/) Industries [Healthcare services](https://www.materialinsights.org/industries/healthcare/)[E-commerce and digital marketplaces](https://www.materialinsights.org/industries/ecommerce/)**Examples:** Apollo Pharmacy, MedPlus, CVS Health, Tata 1mg, Jan Aushadhi Kendras ## Other sections - [Overview](https://www.materialinsights.org/industries/pharmaceuticals/index.md) - [Where ₹100 goes](https://www.materialinsights.org/industries/pharmaceuticals/cost-mix/index.md) - [Price links with suppliers](https://www.materialinsights.org/industries/pharmaceuticals/price-links/index.md) - [Example story](https://www.materialinsights.org/industries/pharmaceuticals/story/index.md) - [Linked industries](https://www.materialinsights.org/industries/pharmaceuticals/linked-industries/index.md) - [Materials drawn on](https://www.materialinsights.org/industries/pharmaceuticals/materials/index.md) - [Chokepoints and risks](https://www.materialinsights.org/industries/pharmaceuticals/risks/index.md) - [Sources](https://www.materialinsights.org/industries/pharmaceuticals/sources/index.md)